The price of Cochlear stock soared after word of a recall by rival Sonova. Cochlear is an Australian company that dominates the cochlear implant business. It gained the most during 2010 in Australian trading after Sonova announced it was voluntarily recalling its HiRes 90K cochlear implant. At one point, Cochlear advanced 4.1 percent to hit $77.96 on the Australian stock exchange.